Virtus ETF Advisers’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,568
| Closed | -$70.2K | – | 660 |
|
|
2024
Q4 | $70.2K | Buy |
9,568
+674
| +8% | +$4.95K | 0.03% | 377 |
|
|
2024
Q3 | $66.6K | Buy |
8,894
+156
| +2% | +$1.17K | 0.03% | 433 |
|
|
2024
Q2 | $77.8K | Buy |
8,738
+108
| +1% | +$961 | 0.04% | 417 |
|
|
2024
Q1 | $87.4K | Sell |
8,630
-591
| -6% | -$5.99K | 0.05% | 385 |
|
|
2023
Q4 | $92.8K | Buy |
9,221
+5,419
| +143% | +$54.5K | 0.06% | 393 |
|
|
2023
Q3 | $35.6K | Sell |
3,802
-377
| -9% | -$3.53K | 0.02% | 424 |
|
|
2023
Q2 | $103K | Buy |
4,179
+274
| +7% | +$6.72K | 0.06% | 370 |
|
|
2023
Q1 | $90.9K | Sell |
3,905
-1,503
| -28% | -$35K | 0.05% | 361 |
|
|
2022
Q4 | $137K | Buy |
5,408
+713
| +15% | +$18K | 0.07% | 373 |
|
|
2022
Q3 | $91K | Buy |
4,695
+36
| +0.8% | +$698 | 0.04% | 424 |
|
|
2022
Q2 | $119K | Buy |
4,659
+1,285
| +38% | +$32.8K | 0.04% | 388 |
|
|
2022
Q1 | $87K | Sell |
3,374
-194
| -5% | -$5K | 0.04% | 324 |
|
|
2021
Q4 | $149K | Sell |
3,568
-1,096
| -23% | -$45.8K | 0.06% | 352 |
|
|
2021
Q3 | $203K | Sell |
4,664
-248
| -5% | -$10.8K | 0.09% | 265 |
|
|
2021
Q2 | $232K | Sell |
4,912
-4,302
| -47% | -$203K | 0.1% | 239 |
|
|
2021
Q1 | $472K | Buy |
9,214
+170
| +2% | +$8.71K | 0.2% | 154 |
|
|
2020
Q4 | $242K | Buy |
9,044
+43
| +0.5% | +$1.15K | 0.1% | 322 |
|
|
2020
Q3 | $309K | Sell |
9,001
-1,225
| -12% | -$42.1K | 0.16% | 214 |
|
|
2020
Q2 | $419K | Buy |
+10,226
| New | +$419K | 0.2% | 183 |
|